Free Trial

ANGLE (AGL) Competitors

ANGLE logo
GBX 8.40 0.00 (0.00%)
As of 05/9/2025 12:42 PM Eastern

AGL vs. SSY, FME, BNR, CON, AMED, SHC, TALK, AMS, DXRX, and YGEN

Should you be buying ANGLE stock or one of its competitors? The main competitors of ANGLE include Scisys Group (SSY), Future Metals (FME), Burning Rock Biotech (BNR), Connemara Mining (CON), Amedeo Resources (AMED), Shaftesbury Capital (SHC), TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Diaceutics (DXRX), and Yourgene Health (YGEN).

ANGLE vs.

ANGLE (LON:AGL) and Scisys Group (LON:SSY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

18.8% of ANGLE shares are held by institutional investors. 16.2% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, ANGLE's average media sentiment score of 0.00 equaled Scisys Group'saverage media sentiment score.

Company Overall Sentiment
ANGLE Neutral
Scisys Group Neutral

ANGLE received 78 more outperform votes than Scisys Group when rated by MarketBeat users. Likewise, 62.46% of users gave ANGLE an outperform vote while only 42.34% of users gave Scisys Group an outperform vote.

CompanyUnderperformOutperform
ANGLEOutperform Votes
183
62.46%
Underperform Votes
110
37.54%
Scisys GroupOutperform Votes
105
42.34%
Underperform Votes
143
57.66%

Scisys Group has a net margin of 0.00% compared to ANGLE's net margin of -890.91%. Scisys Group's return on equity of 0.00% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
ANGLE-890.91% -76.01% -29.89%
Scisys Group N/A N/A N/A

Scisys Group has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Scisys Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ANGLE£2.44M11.08-£21.76M-£6.76-1.24
Scisys Group£59.06M0.00N/A£1.40N/A

ANGLE presently has a consensus target price of GBX 40, suggesting a potential upside of 376.19%. Given ANGLE's stronger consensus rating and higher probable upside, equities analysts clearly believe ANGLE is more favorable than Scisys Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Scisys Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

ANGLE beats Scisys Group on 7 of the 13 factors compared between the two stocks.

Get ANGLE News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

MetricANGLEDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£27.07M£781.74M£5.33B£2.64B
Dividend Yield1.12%5.44%5.45%4.84%
P/E Ratio-1.241.9022.62131.05
Price / Sales11.08468.14393.05248,510.70
Price / Cash5.8011.4238.4128.54
Price / Book0.922.726.634.57
Net Income-£21.76M£308.37B£3.23B£5.84B
7 Day PerformanceN/A-1.30%-1.77%1.32%
1 Year Performance-60.00%-11.91%15.45%27.07%

ANGLE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
ANGLE
1.4137 of 5 stars
GBX 8.40
flat
GBX 40
+376.2%
-60.0%£27.07M£2.44M-1.24650
SSY
Scisys Group
N/AN/AN/AN/A£75.14M£59.06M180.711,376
FME
Future Metals
N/AGBX 0.52
flat
N/A-62.3%£5.94M£155,836.16-1.51123,200Gap Up
BNR
Burning Rock Biotech
N/AN/AN/AN/A£3.77MN/A0.001,390Gap Down
High Trading Volume
CON
Connemara Mining
N/AN/AN/AN/A£1.52MN/A-3.83N/A
AMED
Amedeo Resources
N/AN/AN/AN/A£0.00N/A0.0020,000
SHC
Shaftesbury Capital
N/AGBX 143.50
+2.4%
GBX 174
+21.3%
+0.9%£2.78B£241.46M69.813,000
TALK
TalkTalk Telecom Group
N/AN/AN/AN/A£1.11B£1.52B7.57500High Trading Volume
AMS
Advanced Medical Solutions Group
N/AGBX 196
-4.2%
GBX 300
+53.1%
-5.3%£423.22M£132.18M37.9810
DXRX
Diaceutics
1.9431 of 5 stars
GBX 118.60
-2.1%
GBX 160
+34.9%
+24.4%£100.09M£26.08M-35.17151Positive News
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253

Related Companies and Tools


This page (LON:AGL) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners